Kato, S., Takahashi, T., Miyata, N., & Roman, R. J. (2020). DMOG, a Prolyl Hydroxylase Inhibitor, Increases Hemoglobin Levels without Exacerbating Hypertension and Renal Injury in Salt-Sensitive Hypertensive Rats. J Pharmacol Exp Ther.
Citação norma ChicagoKato, Sota, Teisuke Takahashi, Noriyuki Miyata, and Richard J. Roman. "DMOG, a Prolyl Hydroxylase Inhibitor, Increases Hemoglobin Levels Without Exacerbating Hypertension and Renal Injury in Salt-Sensitive Hypertensive Rats." J Pharmacol Exp Ther 2020.
MLA CitationKato, Sota, Teisuke Takahashi, Noriyuki Miyata, and Richard J. Roman. "DMOG, a Prolyl Hydroxylase Inhibitor, Increases Hemoglobin Levels Without Exacerbating Hypertension and Renal Injury in Salt-Sensitive Hypertensive Rats." J Pharmacol Exp Ther 2020.